These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 25605353)

  • 21. Clinical and economic impact of multidrug resistance in nosocomial Acinetobacter baumannii bacteremia.
    Lee NY; Lee HC; Ko NY; Chang CM; Shih HI; Wu CJ; Ko WC
    Infect Control Hosp Epidemiol; 2007 Jun; 28(6):713-9. PubMed ID: 17520546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug treatment for multidrug-resistant Acinetobacter baumannii infections.
    Bassetti M; Righi E; Esposito S; Petrosillo N; Nicolini L
    Future Microbiol; 2008 Dec; 3(6):649-60. PubMed ID: 19072182
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-transmission of multidrug-resistant Acinetobacter baumannii clonal strains causing episodes of sepsis in a trauma intensive care unit.
    Markogiannakis A; Fildisis G; Tsiplakou S; Ikonomidis A; Koutsoukou A; Pournaras S; Manolis EN; Baltopoulos G; Tsakris A
    Infect Control Hosp Epidemiol; 2008 May; 29(5):410-7. PubMed ID: 18419362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and Characterization of a Novel
    Wintachai P; Surachat K; Singkhamanan K
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventative treatment with Fluorothiazinon suppressed Acinetobacter baumannii-associated septicemia in mice.
    Bondareva NE; Soloveva AV; Sheremet AB; Koroleva EA; Kapotina LN; Morgunova EY; Luyksaar SI; Zayakin ES; Zigangirova NA
    J Antibiot (Tokyo); 2022 Mar; 75(3):155-163. PubMed ID: 35064243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Investigation of the virulence factors of multidrug-resistant Acinetobacter baumannii isolates].
    Eraç B; Yılmaz FF; Hoşgör Limoncu M; Oztürk I; Aydemir S
    Mikrobiyol Bul; 2014 Jan; 48(1):70-81. PubMed ID: 24506717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Acinetobacter baumannii: an important pathogen with multidrug resistance in newborns].
    Celik IH; Demirel G; Tatar Aksoy H; Saygan S; Canpolat FE; Uras N; Oğuz SS; Erdeve O; Dilmen U
    Mikrobiyol Bul; 2011 Oct; 45(4):716-22. PubMed ID: 22090302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-multidrug-resistant Acinetobacter baumannii activity of DS-8587: In vitro activity and in vivo efficacy in a murine calf muscle infection model.
    Higuchi S; Kurosaka Y; Uoyama S; Yoshida K; Chiba M; Ishii C; Fujikawa K; Karibe Y; Hoshino K
    J Infect Chemother; 2014 May; 20(5):312-6. PubMed ID: 24594453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activity of eravacycline against Enterobacteriaceae and Acinetobacter baumannii, including multidrug-resistant isolates, from New York City.
    Abdallah M; Olafisoye O; Cortes C; Urban C; Landman D; Quale J
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1802-5. PubMed ID: 25534744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of Acinetobacter infections.
    Michalopoulos A; Falagas ME
    Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand.
    Anunnatsiri S; Tonsawan P
    Southeast Asian J Trop Med Public Health; 2011 May; 42(3):693-703. PubMed ID: 21706949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii.
    Liu B; Bai Y; Liu Y; Di X; Zhang X; Wang R; Wang J
    J Chemother; 2015 Oct; 27(5):271-6. PubMed ID: 25068186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk factors of multidrug resistance in nosocomial bacteremia due to Acinetobacter baumannii: a case-control study.
    Shih MJ; Lee NY; Lee HC; Chang CM; Wu CJ; Chen PL; Ko NY; Ko WC
    J Microbiol Immunol Infect; 2008 Apr; 41(2):118-23. PubMed ID: 18473098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cationic amphiphilic alpha-helical peptides for the treatment of carbapenem-resistant Acinetobacter baumannii infection.
    Huang Y; Wiradharma N; Xu K; Ji Z; Bi S; Li L; Yang YY; Fan W
    Biomaterials; 2012 Dec; 33(34):8841-7. PubMed ID: 22925814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk and Prognostic Factors for Multidrug-Resistant Acinetobacter Baumannii Complex Bacteremia: A Retrospective Study in a Tertiary Hospital of West China.
    Liu Q; Li W; Du X; Li W; Zhong T; Tang Y; Feng Y; Tao C; Xie Y
    PLoS One; 2015; 10(6):e0130701. PubMed ID: 26083415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Microbiological features and risk factors for acquiring multidrug-resistant Acinetobacter baumannii bacteremia in pediatric patients. Case-control study].
    Ruvinsky S; Fiorilli G; Pérez MG; Motto E; Cambaceres C; Mannino L; Lopardo H; Bologna R
    Rev Chilena Infectol; 2015 Feb; 32(1):19-24. PubMed ID: 25860039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Inactivated Antibiotic-Exposed Whole-Cell Vaccine Enhances Bactericidal Activities Against Multidrug-Resistant Acinetobacter baumannii.
    Shu MH; MatRahim N; NorAmdan N; Pang SP; Hashim SH; Phoon WH; AbuBakar S
    Sci Rep; 2016 Feb; 6():22332. PubMed ID: 26923424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro activity of doripenem in combination with various antimicrobials against multidrug-resistant Acinetobacter baumannii: possible options for the treatment of complicated infection.
    Principe L; Capone A; Mazzarelli A; D'Arezzo S; Bordi E; Di Caro A; Petrosillo N
    Microb Drug Resist; 2013 Oct; 19(5):407-14. PubMed ID: 23659601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidrug-resistant Acinetobactor baumannii isolated from a traveler returned from Brunei.
    Tojo M; Mawatari M; Hayakawa K; Nagamatsu M; Shimada K; Mezaki K; Sugiki Y; Kuroda E; Takeshita N; Kutsuna S; Fujiya Y; Miyoshi-Akiyama T; Kirikae T; Ohmagari N
    J Infect Chemother; 2015 Mar; 21(3):212-4. PubMed ID: 25444675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.